Defective NET clearance contributes to sustained FXII activation in COVID-19-associated pulmonary thrombo-inflammation
Background: Coagulopathy and inflammation are hallmarks of Coronavirus disease 2019 (COVID-19) and are associated with increased mortality. Clinical and experimental data have revealed a role for neutrophil extracellular traps (NETs) in COVID-19 disease. The mechanisms that drive thrombo-inflammatio...
Main Authors: | Hanna Englert, Chandini Rangaswamy, Carsten Deppermann, Jan-Peter Sperhake, Christoph Krisp, Danny Schreier, Emma Gordon, Sandra Konrath, Munif Haddad, Giordano Pula, Reiner K. Mailer, Hartmut Schlüter, Stefan Kluge, Florian Langer, Klaus Püschel, Kosta Panousis, Evi X. Stavrou, Coen Maas, Thomas Renné, Maike Frye |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-05-01
|
Series: | EBioMedicine |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352396421001754 |
Similar Items
-
Lower FXII activity and thrombosis: a comment
by: Viroj Wiwanitkit
Published: (2010-06-01) -
Mutant plasminogen in hereditary angioedema is bypassing FXII/kallikrein to generate bradykinin
by: Stefan Hintze, et al.
Published: (2023-01-01) -
Platelet in thrombo-inflammation: Unraveling new therapeutic targets
by: Swati Sharma, et al.
Published: (2022-11-01) -
The FXII c.-4T>C Polymorphism as a Disease Modifier in Patients With Hereditary Angioedema Due to the FXII p.Thr328Lys Variant
by: Fernando Corvillo, et al.
Published: (2020-09-01) -
Oral FXIIa inhibitor KV998086 suppresses FXIIa and single chain FXII mediated kallikrein kinin system activation
by: Allen C. Clermont, et al.
Published: (2023-12-01)